Viraj Master, MD, PhD, FACS

Viraj  Master, MD, PhDAssociate Professor of Urology

Director of Clinical Research

Associate Chair for Quality and Clinical Affairs

Clinical Practice Sites

Emory University Hospital
(404) 778-0963

Grady Memorial Hospital
(404) 616-4466

Undergraduate Education

Northwestern University – BA (1988)

Graduate & Postgraduate Degrees

University of Chicago – PhD (1995)

Medical School

The University of Chicago (1997)

Urology Residency

University of California San Francisco (1997-2003)

Fellowship

Fellowship in Urologic Oncology (2003-2004)
University of California San Francisco
Fellowship in Reconstructive Urology & Trauma (2004-2005)
University of California San Francisco

Board Certification

American Board of Urology (2006)

Clinical and Academic Appointments

University of California San Francisco (2003-2005)
Emory University School of Medicine (2005-current)

Primary Clinical Interests

Kidney Cancer
Penile Cancer
Adrenal Cancer
Adrenal Mass

All Areas of Clinical Interest

tumor
prostate cancer
kidney cancer
bladder cancer/tumors
testicular cancer
urethral strictures
laparoscopic surgery
adrenal masses
benign prostatic hyperplasia
urinary diversion
renal cancer
robotic surgery
prostate cancer - robotics

Year Started Practice:

2003

Year Started at Emory:

2005

See full curriculum vitae

About Dr. Master

Dr. Master is an Associate Professor of Urology at the Emory University School of Medicine, Associate Chair for Clinical Affairs and Quality, and Director of Clinical Research Unit.

Following his undergraduate education at Northwestern University, Dr. Master attended medical school at the University of Chicago where he received both MD and PhD degrees. He completed his urology residency and two fellowships training at the University of California in San Francisco (UCSF) before joining the Department of Urology at Emory University in 2005. Dr. Master is a diplomate of the American Board of Urology (2006) a Fellow of the American College of Surgery (FACS).

Dr. Master’s primary clinical interest is urologic oncology, in particular kidney cancer, adrenal tumors, testicular cancer, high-risk prostate cancer and penile cancers. Dr. Master is a renowned national expert in the surgical treatment of kidney cancer particularly a complex variety that extends into the main blood vessels and the heart. He also has a special interest in minimally invasive laparoscopic technique that removes of cancerous lymph nodes with minimal interference with the patients’ quality of life.

As the Director of Clinical Research, he is active in investigating the role of inflammation in cancers and in researching “host” (patient) interaction with the disease. In his role as Associate Chair for Clinical Affairs and Quality, he works closely with all faculty members towards a common goal of providing the highest quality of care to our patients. Emory University Hospital (EUH) ranks number one hospital (out of 187) in both Georgia and metro Atlanta (2013-2014 U.S. News & World Report), and the Department of Urology ranks as one of Emory’s top ten high-performing adult specialty areas.

Dr. Master serves as an expert advisor to the American Cancer Society on prostate cancer and to the International Consultation on Urologic Diseases on kidney cancer. He has lectured both nationally and internationally. He is closely involved in teaching and mentoring medical students, urology residents and post-graduate fellows. He has authored multiple book chapters and scientific journal articles.

In addition to his dedication to Emory patients, Dr. Master is also involved in humanitarianism outside Emory. On an annual basis, he volunteers his time to join a team of Emory medical students to Haiti. The team provides free urologic care including surgical treatment to indigent Haitian patients with urologic conditions. 

Honors & Awards

Best Young Investigator Award (2013)
American Urological Association (AUA) Research Foundation

Scientific Research Prize (2011)
American Urological Association/Olympus Prize Essay Contest

Scientific Research Prize (2010)
American Urological Association/Olympus Prize Essay Contest

Best Scientific Poster Presentation (Clinical/Epidemiology/Healthcare) (2009)
American Medical Association (7th Annual)

Best Scientific Poster Presentation (Public Health Award) (2009)
National Student Research Forum (50th Annual)

Best Scientific Essay Award (Transitional Medicine) (2008)
National Student Research Forum (49th Annual)

Best Scientific Poster Presentation (2007)
American Urological Association (AUA) Annual Convention

First Prize – Clinical Research (2007)
American medical Student Association (57th Annual)

Resident Scholarship Award (2001 & 2002)
American Urological Association (AUA) Western Section

Gerald P. Murphy Scholar - Prostate Cancer (2002)
American Urological Association (AUA) / Praecis

First Prize – Resident Research (2000)
Northern California Urological Association

NIH - Medical Scientist Training Grant Award

Publications

Finnerty JR, Master VA, Irvine S, Kourakis MJ, Warriner S, Martindale MQ. Homeobox genes in the Ctenophora: identification of paired-type and Hox homologues in the atentaculate ctenophore, Beroe ovata. 1996.  Molecular Marine Biology and Biotechnology. Dec;5(4):249-58

Kourakis MJ, Master VA, Lokhorst DK, Nardelli-Haefliger D, Wedeen CJ, Martindale MQ, Shankland M.  Conserved anterior boundaries of Hox gene expression in the central nervous system of the leech Helobdella.  Developmental Biology. 1997 Oct 15;190(2):284-300

Master VA, McAninch JW, Santucci RA. Genital self-mutilation and the Internet.  Journal of Urology. 2000 Nov;164(5):1656

Master VA, Turek PJ.  Ejaculatory physiology and dysfunction.  Urologic Clinics of North America. 2001 May;28(2):363-75

Damani M, Master VA, Meng MV, Burgess C, Turek PJ, Oates RD. 
Post-chemotherapy persistent azoospermia:  successful treatment with testis sperm extraction and intracytoplasmic sperm injection.  Journal of Clinical Oncology. Feb 15;20(4):930-6

Master VA, Meng MV, Koppie TM, Carroll PR, Grossfeld GD.  Origin of urothelial carcinoma after renal transplantation determined by FISH (fluorescence in situ hybridization).  Journal of Urology. 2002 Jun:167(6):2521

Master VA, Franks J, McAninch JW.  Grade V Renal Injury.  Journal of the American College of Surgeons. 2002 Sep;195(3);425

Cooperberg M, Master VA, Carroll PR.  Health-related quality of life significance of single pad urinary incontinence following radical prostatectomy.  Journal of Urology. 2003 Aug;170(2 Pt 1):512-5

Master VA, Wei G, Liu W, Baskin LS.  Urothelium facilitates Recruitment and Trans-Differentiation of Fibroblasts into Smooth Muscle in Acellular Matrix. Journal of Urology. 2003 October;170(2 Part 2):1628-1632

Master VA, Meng MV, Grossfeld GD, Koppie TM, Hirose R, Carroll PR. Treatment and Outcome of Invasive Bladder Cancer in patients after Renal Transplantation.  Journal of Urology. Mar;171(3):1085-8

Master VA, Santucci RA.  An American Hijra:  An American Hijra: A Report of a Case of Genital Self-Mutilation to Become India’s Third Sex.  Urology 2003 62(6):1121

Turek, PJ, Master VA.  Safety and Effectiveness of a New Saline Filled Testicular Prosthesis.  Journal of Urology. 2004 Oct;172:1427

Master VA, Shinohara K, Carroll PR.  Ferromagnetic thermal ablation therapy of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities.  Journal of Urology. 2004 Dec;172(6 Pt 1):2197

Anast JW, Stoller ML, Meng MV, Master VA, Mitchell JA, Bassett WW, Kane CJ.  Differences in complications and outcomes for obese patients undergoing laparoscopic radical, partial or simple nephrectomy.  Journal of Urology 2004 Dec;172:2287

Doyle SM*, Master VA, McAninch JW.  Appropriate Use of CT in the Diagnosis of Bladder Rupture.  Journal of the American College of Surgeons. 2005 Jun;200(6):973

Master VA, Gottschalk AR, Carroll PR.  Management of Patients with Isolated Renal Fossa Recurrence Following Radical Nephrectomy.  Journal of Urology 2005. Aug;174;473

Master VA, Chi T*, Simko JP, Weinberg VK, Carroll PR.  The Independent Impact of Extended Pattern Biopsy on Prostate Cancer Stage migration.  Journal of Urology 2005 Nov;174;1789

Master VA, McAninch JW.  Operative Management of Renal Injuries:  Parenchymal and Vascular.  Urologic Clinics 2006 Feb; 33(1) 21-31.

Eisenberg, M, Meng MV, Master VA, Stoller ML, Rini BI, Carroll PR, Kane CJ.  Laparoscopic versus Open Cytoreductive Nephrectomy in Advanced Renal Cell Carcinoma.  J Endourol. 2006 20(7):504

Elliott SP*, McAninch JW, Chi T*, Doyle SM*, Master VA. Management of severe urethral complications of prostate cancer therapy.  J Urol. 2006 176(6):2508

Breyer BN*, Master VA, Marder SR, McAninch JW. Endovascular Management of Trauma Related Renal Artery Thrombosis. J Trauma. 2006 Nov 13

Schuster DM, Votaw JR, Nieh PT, Yu W, Nye JA, Master V, Bowman FD, Issa MM, Goodman, M. Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.  J Nucl Med 2007 48(1):56-63.  This made the cover of Journal of Nuclear Medicine

Johnstone PA, Assikis V, Goodman M, Ward KC, Riffenbaugh RH, Master VA.  Lack of Survival Benefit of Post-Operative Radiation Therapy in Prostate Cancer Patients with Positive Lymph Nodes.  Prostate Cancer Prostatic Dis 2007 Jan 9

Johnstone PA, Rossi PJ, Jani AB, Master V.  ‘Insignificant' prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy. Prostate Cancer Prostatic Dis. 2007 March 27

Johnson TV*, Goodman M, Master VA.  The Efficacy of Written Screening Tools in Inner-City Hospitals:  Literacy-based limitations on patient access to appropriate care.  J. Urol 2007 178:623-9

Brawley OW, Jani AB, Master V.  Prostate cancer and race.  Curr Probl Cancer 2007. 31(3) 211-5

Young AN, Master VA, Amin MB.  Current Trends in the Molecular Classification of Renal Neoplasms. Scientific World Journal 2006 6:2505-18

Jani AB, Master VA, Rossi PJ, Liauw SL, Johnstone PA.  Grade migration in prostate cancer:  an analysis using the Surveillance, Epidemiology and End Results Registry.  Prostate Cancer Prostatic Dis.  2007(10):347-51

Johnstone PA, Riffenbaugh RH, Rossi, PJ Assikis V, Master V, Jani AB.  Applying Population Dynamics Modeling to Patients with Lymph Node Positive Prostate Cancer.  J Urol. 2007 178:1952-5

Moses KM*, Tillett JW*, Master VA. Primary Penile Angiosarcoma in a Patient with AIDS: a case report.  AIDS 2007, 21:2355-6

Jani AB, Johnstone PA, Liauw SL, Master VA, Brawley OW.  Age and Grade Trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.  Am J Clin Oncol 2008:375-8

Young AN, Master VA, Paner GP, Wang MD, Amin MB.  Renal epithelial neoplasm:  diagnostic applications of gene expression profiling.  Adv Anat Path 2008.  15:28-38

Breyer BN*, McAninch JW, Elliott SP, Master VA.  Minimally Invasive Endovascular Techniques to Treat Acute Renal Hemorrhage.  J Urol. June 2008

Johnson TV*, Goodman M, Master VA.  Patient Misunderstanding of the Individual Questions of the American Urological Association Symptom Score.  J. Urol. 2008:179:2991-4

Dall’Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR.  Active Surveillance for the management of prostate cancer in a contemporary cohort.  Cancer 2008.
112:2664-70

Phonsombat S*, Master VA, McAninch JW.  Penetrating external genital trauma:  a 30 year single institution experience.  J Urol 2008.  180:192-5

Robinson D*, Johnson TV*, Master VA.  Re: The efficacy of written screening tools in an inner city hospital: literacy-based limitations on patient access to appropriate care. J Urol 2008 180(4)1573-5 (this is a peer-reviewed letter to the editor with original research by student David Robinson)

Jani AB, Johnstone PA, Liauw SL, Master VA, Brawley OW. Age and Grade Trends in Prostate Cancer (1974-2003): A Surveillance, Epidemiology, and End Results Registry Analysis.  Amer J Clin Oncol 2008, 31:375-84

Johnson TV*, Schoenberg ED*, Abbasi A*, Erlich SS*, Kleris R*, Owen-Smith A*, Gunderson K*, Master VA.  Assessment of the Performance of the AUA-SS in Two Distinct Patient Populations.  J Urol 2009 181(1) 230-7

Jani AB, Fox TH, Blaustein D, Rossi PJ, Johnstone PA, Master VA.   Pelvic Shape and Prostate Motion:  Implications for Target Volume Design and Analysis of Acute Toxicity.  Amer J Clin Oncol June 2009; 32(3): 291-295

Rossi PJ, Schreibmann E, Jani AB, Master VA, Johnstone PA.  Boost First, Eliminate Systematic Error and Individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer. Radiotherapy and Oncology. March 2009; 90(3): 353-358.

Subramanian A, Rozycki GS, Master VA.  Ureteropelvic junction disruption after blunt abdominal trauma.  J Trauma 2009 Jan66(1):287

Yezhelyev M, Master VA, Egnatashvilli V, Kooby DK.  Combined Nephrectomy and Major Hepatectomy:  Indications, Outcomes and Recommendations.  J Am Coll Surg 2009 208: 410-8

Natarajan V*, Master V, Ogan K. Effects of obesity and weight loss in patients with nononcological urological disease.  J Urol 2009 181:  2424-9

Breyer BN*, McAninch JW, Whitson JM, Eisenberg ML, Master VA, Voelzke BB, Elliott SP.  Effect of Obesity on Urethroplasty Outcome.  Urology 2009 73:1352-5

Breyer BN*, Cooperberg MR, McAninch JW, Master VA.  Improper Retrograde Urethrogram Technique Leads to Incorrect Diagnosis.  J Urol 2009 182: 716-717

Bryant MD*, Schoenberg ED*, Johnson TV*, Goodman M, Owen-Smith A*, Master VA.  A Multimedia Version of a Standard Medical Questionnaire Improves Patient Understanding Across All Literacy Levels.  J Urol 2009 182: 1120-5

Master VA, Ogan K, Kooby D, Hsiao W*, Delman K.  Leg Endoscopic Groin Lymphadenectomy (LEG procedure):  Step-by-step Approach to a Straightforward Technique.  Eur Urol 2009. 
Article highlighted on the cover

Master VA, Johnson TV*, Abbasi A*, Ehrlich SS*, Kleris RS*, Abbasi S*, Prater A*, Owen-Smith A*, Goodman M. ‘Poorly numerate patients in an inner city hospital misunderstand the American Urological Association symptom score’.  Urology 2010 75(1): 148-152.

Johnson TV*, Osunkoya, AO, Delman K, Baumgarten DA, Master VA. Novel Case of Metastatic Immature Teratoma Invading the Duodenum. The Open Surgical Oncology Journal 2009 1:  16-18.

Johnson TV*, Ogan K, Pattaras J, Nieh P, Master VA.  Absolute Preoperative
C-Reactive Protein Predicts Metastasis and Mortality in the First year Following Potentially Curative Nephrectomy for Clear Cell Renal Cell Carcinoma.  J Urol 2010 183: 480-5

AB Jani, PAS Johnstone, S Liauw, V Master, and PJ Rossi. ‘Prostate Cancer Modality Time Trend Analyses from 1973-2004: A Surveillance, Epidemiology, and End Results (SEER) Registry Analysis’. American Journal of Clinical Oncology 2009 (PMID 19745696 epub ahead of print)

Delman K, Ogan K, Kooby D, Hsiao W*, Master VA.  Feasibility of a Novel Approach to Inguinal Lymphadenectomy.  Ann Surg Oncol 2010 (PMID 19921337, epub ahead of print)

Saint-Elie DT*, Patel PV*, Healy KA*, Solomon T, Pattaras JG, Qian J, Master VA, Ogan K. The Impact of Income and Education on Dietary Habits in Stone Formers. Urology 2010, (PMID 2018338 epub ahead of print, in press)

Moses KA*, Paciorek A, Penson D, Carroll PR, Master VA.  Impact of Ethnicity on Primary Treatment Choice and Mortality in Men with Prostate Cancer:  Data from CapSURE.  J Clin Oncol (PMID 20100957 epub ahead of print, in press)

Master VA. ‘Body Mass Index (BMI) as a Predictor of Urologic Disease and Outcomes:  Overly Simplistic’? J Urol 2010, 183(2):427-9

Johnson TV*, Delong J, Master VA. Keep looking: Not one but five infectious causes of hematuria.  JAAPA 2010 (in press)

Johnson TV*, Abbasi A*, Ehrlich SS*, Kleris RS*, Chirumamilla SL*, Schoenberg ED*, Owen-Smith A*, Raison CL, Master VA.  ‘Major depression drives severity of American Urological Association Symptom Score’. Urology 2010  [In Press]

Johnson TV*, Abassi A*, Owen-Smith A*, Young AN, Kucuk O, Harris WB, Osunkoya AO, Ogan K, Pattaras J, Nieh PT, Marshall FF, Master VA.  'Postoperative better then preoperative C-Reactive Protein at predicting outcome following potential curative nephrectomy for renal cell carcinoma' Urology 2010 (in press)
Prize-winner 2010 AUA/Olympus Prize Essay Contest (Clinical Research Category)

Johnson TV*, Hsiao W, Delman K, Jani A, Brawley O, Master VA. ‘Extensive inguinal lymphadenectomy improves overall five-year survival in penile cancer patients: Results from the Surveillance, Epidemiology and End Results (SEER) Program’. Cancer 2010. (in press)

Hsiao W*, Moses KA*, Goodman M, Jani AB, Rossi P, Master VA. Stage IV Prostate Cancer: Survival Differences in Clinical T4, Nodal, and Metastatic Disease. J Urol 2010 184(2):512-8
Winner, Montague Boyd Prize Essay Contest 2009 SESAUA

Wolf AM, Wender RC, Etzioni RB, Thompson IM, D’Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA, American Cancer Society Prostate Cancer Advisory Committee*. American Cancer Society guideline for the early detection of prostate cancer: update 2010.  CA Cancer J Clin. 2010 60:70-98. PMID 20200110. *member of this committee, and listed under my name in PubMed.

Johnson TV*, Young AN, Osunkoya AO, and VA Master. C-reactive protein: A clinically useful biomarker for metastasis of renal cell carcinoma. Mol Diagn Ther. 2010 14(3):191-3

Johnson TV*, Delong J, Master VA. Education level predicts low health literacy and risk of patient misunderstanding of written screening tools: Implications for healthcare providers.  JAAPA (accepted)

Johnson TV*, Delong J, Master VA. C-reactive protein: a clinically useful biomarker in renal cell carcinoma.  JAAPA (accepted)

Johnson TV*, Abbasi A*, Erlich SS*, Kleris RS*, Raison CL, Master VA.  Nocturia associated with depressive symptoms.  Urology 2010 (in press)

Johnson TV*, Bond N, Master VA.  Radical Nephrectomy via Epidural-only anesthesia.  Can J Urol. 17(5):5401-2

Johnson TV, Master VA.  Decreased Cancer Survival in individuals separted at time of diagnosis: Critical period for cancer pathophysiology. Cancer 2010 July 21.

Johnson TV*, Young AN, Force SD, Master VA. C-reactive protein may represent sensitive measure of renal carcinoma metastases.  Urol Nurs Feb 2011 (in press)

Abbasi A*, Johnson TV*, Master VA. Minor symptoms should alert suspicion of metastatic renal cell carcinoma after curative nephrectomy.  J Clin Oncol 2010 (in press)

Johnson TV* and Master VA. Non-malignant drivers of elevated C-reactive protein differ in patients with and without a history of cancer.  Mol Diagn Ther 2010 14(5):295-303

Johnson TV*, Jani AB, Master VA. Increased mortality among Hispanic testis cancer patients independent of neighborhood socioeconomic status: A SEER Study.  Journal of Immigrant and Minority Health 2010 (in press)

Hwang C*, Ogan K, Pattaras JG, Master VA. Three-dimensional growth characteristics of renal tumors undergoing active surveillance. 2010 Can J Urol (in press)

Savir-Baruch B, Schuster DM, Jarkas N, Master VA, Nieh PT, Halkar RK, Nye JA, Lewis MM, Crowe RJ, Voll RJ, Camp VM, Bellamy LM, Roberts DL, Goodman MM.  Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma" Molecular Imaging & Biology.(in press)

S Ali, AN Young, TV Johnson*, Q Yin-Goen, NA Johnson, W Harris, VA Master, and AO Osunkoya. Expression of CRP and COX-2 in Clear Cell Renal Cell Carcinoma: Correlation with Pathological Parameters in 110 Patients. Tumor Biol 2010. Nov 18

Johnson TV*, Garlow S, Brawley OW, Master VA. Majority of suicides among cancer patients occur within the first month of diagnosis: Implications for clinical oncology.  Psycho-Oncology

Figler B*, Kirsch A, Master VA.  Pediatric Traumatic Adrenal Injury in the 21st Century: Children’s Hospital of Atlanta Experience.  J Urol (in press)

Schuster DM, Nieh PT, Master VA, Goodman MM. "Recurrent prostate carcinoma detection with anti-1 amino 3 [18F] fluorocyclobutane-1-carboxylic acid (anti-[18F] FACBC) PET-CT and 111Indium-capromab-pendetide (ProstaScint) SPECT-CT.  Radiology 2010 (accepted)

Chin-Quee A*, White L*, Leeds I*, MacLeod J, Master VA.  Medical Student Surgery Elective in Rural Haiti:  A novel approach to satisfying typical third year medical student requirements while providing surgical care to an underserved population.  World J Surg 2011 in press

Goodman M, Master VA, etc.  Prostate cancer treatment ascertained from several sources:  analysis of disagreement.  Ann Oncol. 2011 accepted 

Shelton J, Rossi PJ, Chen H, Liu Y, Master VA , Jani AB. Observations on Intrafraction Prostate Motion and the Effect of Reduced Treatment Time Using Volumetric Modulated Arc Therapy". Practical Radiation Oncology 2011 accepted

Michigan A*, Johnson TV*, Master VA.  Preoperative CRP adjusted for comorbidities and lifestyle factors predicts overall mortality for localized renal cell carcinoma.  Mol Diag Thera 2011 accepted

Creigton FX*, Leeds I*, Master VA, Srinivasan JK. Learning from Haiti: Portable Ultrasound’s Role in Humanitarian Surgical Mission.  Lancet 2011 (accepted)

Hsiao W, Moses KA, Shrewsberry AB*, Malek-Jones, M, Baumgarten D, Master VA, Ogan K.  Intra-tumor Doppler Flow Patterns Do Not Predict Malignancy of Renal Masses in a United States Population.  Canadian J Urol 2011 (accepted)

Michigan A, Johnson TV, Master VA. A review of the relationship between C-Reactive Protein and Exercise.  Mol Diag Thera 2011 published

Abbasi A*, Milner R, Baumgarten DA, Master VA.  Duplicated Vena Cava with Tumor Thrombus from Renal Cancer: Use of Venogram for Safer Operative Planning.  Urology (accepted)

Abbasi A*, Master VA. Posterior Lumbar Vein Inserting Into The Retrohepatic Vena Cava: A Novel Anatomical Variant With Surgical Implications.  J Urol 2012. This article was featured on the cover of the Journal of Urology

Johnson TV*, Ali S, Abbasi A*, Kucuk O, Ogan K, Pattaras J, Nieh PT, Marshall FF, Osunkoya AO, Master VA.  Intratumor C-Reactive Protein as a Biomarker of Prognosis in Localized Renal Cell Carcinoma.  J Urol 2011 (in press)

Margulis V, Master VA, Cost NG, Leibovich BC, Joniau S, Kuczyk M, Mulders PF, Kirkali Z, Wirth MP, Hirao Y, Rawal S, Chong TW, Wood CG.  International Consultation on Urologic Diseases and the European Association of Urology International Consultation on Locally Advanced Renal Cell Carcinoma. Eur Urol. 2011 Jun 29

IL Leeds, FX Creighton, MA Wheatley, JB Macleod, J Srinivasan, MP Chery and VA Master. Intensive medical student involvement in short-term surgical trips provides safe and effective patient care: a case review.  BMC Research Notes 2011

Amzat R, Taleghani P, Savir-Baruch B, Nieh PT, Master VA, Halkar RK, Lewis MM, Faurot M, Bellamy LM, Goodman MM, Schuster DM.  Unusual Presentations of Metatstatic Prostate Carcinoma as detected by anti-3 F-18 FACBC PET/CT. Clin Nucl Med 2011;36: 800–802

Li J, Master VA.  Association between Smoking Status and Free, Total, and Percent Free Prostate-specific Antigen.  J Urol Apr 2012 (accepted)

Johnson TV*, Delong J, Master VA. Hidden variables: why patients may misunderstand written screening tools.  JAAPA 2011 24(9): 38-40

Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Owen-Smith A, Raison CL, Master VA.  IPSS quality of life question:  a possible indicator of depression among patients with lower urinary tract symptoms.  Can J Urol 2012 6100-6104.

Johnson TV*, Hsiao W, Canter DJ, Master VA.  Scrotal Cancer Survival is influenced by histology:  A SEER study.  World J Urol 2012

Canter D, Angell J, Cross B, DeRosa A, Master V, Ogan K. Percutaneous Antegrade Resection of Renal Pelvic Tumors Using Bipolar PK Button Vaporization: A Novel Technique. J Endourol – VideoUrology B 2012 26(3).

Kunzel B, Cabalza J*, Faurot M, Solomon T, Nieh P, Pattaras J, Master V, Ogan K.  Prospective Pilot Study of Smoking Cessation in Patients Undergoing Urologic Surgery.  Urology 2012

Canter DJ, Ogan K, Master VA.  Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors.  Can J Urol 2012 19(2) 6211-6215

Master VA, Jafri SMA*, Moses KA*, Ogan K, Kooby DA, Delman KA.  Minimally Invasive Inguinal Lymphadenectomy via Endoscopic Groin Dissection: Comprehensive Assessment of Immediate and Long-term Complications.  J Urol 2012 (in press). This article is featured on the cover of the October 2012 issue

Herrell LA*, Canter D, Ogan K, Delman K, Master VA.  Bilateral Endoscopic Inguinofemoral Lymphadenectomy Using Simultaneous Carbon Dioxide Insufflation: An Initial Report of a Novel Approach.  Can J Urol 2012

Cross B*, Johnson T, DeRosa A*, Ogan D, Pattaras J, Nieh P, Kucuk O, Harris W Master V.  Preoperative Erythrocyte Sedimentation Rate independently predicts overall survival in localized renal cell carcinoma following radical nephrectomy. Int J Surg Onc 2012. 

A Molecular Image-directed 3D Ultrasound guided Biopsy System for the Prostate.  Proc SPIE 2012.  Feb 16.  PMID: 22708023

Yang X, OTHERS, Master VA, OTHERS  Chung LW.  Optical Imaging of Kidney Cancer With Novel Near-infrared Heptamethine Carbocyanine Fluorescent Dyes.  J Urol Feb 2013.

Li J, Joseph D, Soman A, Rim S, Master V. Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage and Grade, the United States, 2001-2007.  Prostate Cancer 2013 (accepted)

Schuster DM, Taleghani PA, Nieh, PT, Master VA, Amzat R, OTHERS, Goodman MM.  Charecterization of primary prostate carcinoma by anti-1-amino-2-[18F] -fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake.  Am J Nucl Med Mol Imaging 2013:3 (1) 85-96

Kunzel B, Small W, Goodman M, Pattaras J, Master V, Ogan K.  Computed tomography based renal parenchyma volume measurements prior to renal tumor surgery are predictive of postoperative renal function.  Can J Urol 2013. 20: 6714-20

Akbari H, Halig LV, Schuster DM, Osunkoya A, Master V, Nieh PT, Chen GZ, Fei B.. Hyperspectral imaging and quantitative analysis for prostate cancer detection. J Biomed Opt 2012. July 17(7).  PMID 22894488

Johnson TV, Abbasi A, Master VA. Systematic Review of the Evidence of a Relationship Between Chronic Psychosocial Stress and C-Reactive Protein.  Mol Diag Ther April 2013. 

Wang DS*, Jani AB, Tai CG, Sesay M, Lee DK*, Goodman M, Echt KV, Kilbridge KE, Master VA. Severe lack of comprehension of common prostate health terms among Low-Income Inner-City Men.  Cancer 2013 Jun 3 PMID 23733135

Revenig LM*, Canter DJ, Taylor MD, Tai C, Sweeney JF, Sarmiento JM, Kooby DA, Maithel SK, Master VA, Ogan K. Too Frail for Surgery?: Initial results of a large multidisciplinary prospective study examining pre-operative variables predictive of poor surgical outcomes. Journal Amercian Coll Surgeons 2013, accepted,

Hsiao W, Lian F, Goodgame B, Ritenour CW, Angell J, Master VA. Breakage of Needle during intracavernosal injection and use of portable ultrasound guidance for removal. Case Rep Urol 2013. PMID 23819095

Hall WA, Nickleach DC, 23819095, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB. The Association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. Cancer 2013 Jul 1. PMID 23818401

Lauer SR, Zhou M, Master VA, Osunkoya AO. Chromophobe renal cell carcinoma with sarcomatoid differentiation: a clinicpathologic study of 14 cases. Anal Quant Cytol Histol 2013 Apr 35(2) 77-84 PMID 23700716